Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.
Tag
This multicenter randomized trial in India shows that three dual antihypertensive combinations—amlodipine-perindopril, perindopril-indapamide, and amlodipine-indapamide—are equally effective and well-tolerated for 24-hour blood pressure con
The large-scale COSMOS trial reveals that while long-term cocoa extract supplementation does not reduce overall incident hypertension in older adults, it significantly lowers risk among individuals with normal baseline systolic blood pressu
Isometric exercises, a form of static muscle engagement, can lower blood pressure as effectively as some medications, offering a simple, drug-free way to protect your heart and vessels.
TEAMLET trial reveals limited impact of EHR-pharmacy linked interventions on medication adherence in hypertension, highlighting complexity of adherence barriers and the need for multifaceted, patient-centered strategies.
A novel inhibitor AH001 targets the TRPV4-RhoA-RhoGDI1 axis to inactivate RhoA signaling, effectively reducing blood pressure and preventing vascular remodeling in hypertensive models, opening new avenues for antihypertensive drug developme
Incorrect arm positioning during blood pressure measurement can significantly overestimate readings, impacting diagnosis and treatment decisions. Learn the science and best practices for accurate blood pressure monitoring.
The new hypertension management guidelines emphasize individualized treatment approaches based on recent evidence, aiming to improve cardiovascular health outcomes.
This nationwide Korean cohort study found that hysterectomy is associated with a modestly increased risk of developing hypertension in women aged 40 to 59 years, particularly in those with elevated post-surgical hemoglobin levels and after
The SMART-BP trial demonstrates that a mobile app providing tailored feedback significantly improves systolic blood pressure reduction and drug adherence compared to self-monitoring alone, highlighting innovative digital solutions in hypert
This review integrates data from over two million individuals globally, showing that absence of five key cardiovascular risk factors at age 50 confers a life expectancy advantage exceeding a decade, with midlife modification of hypertension
The SPYRAL HTN-ON MED trial demonstrates that renal denervation provides significant long-term reductions in both ambulatory and office systolic blood pressure with good safety, supporting its role in managing hypertension.
This study assesses the impact of β-blocker interruption on blood pressure and heart rate following myocardial infarction, revealing significant increases associated with treatment cessation, particularly in hypertensive patients.
This study demonstrates the superior effectiveness of remote monitoring in reducing blood pressure among hypertensive patients compared to usual care and self-monitoring.
This study highlights the association between the triglyceride-glucose index and the incidence of hypertension in Japanese adults, emphasizing its potential as a predictive marker for cardiovascular health.
This article explores the associations between pregnancy complications and the risk of ischemic stroke in young women, highlighting the importance of early identification for preventive measures.
Lorundrostat, an aldosterone synthase inhibitor, significantly reduced systolic blood pressure in adults with uncontrolled and treatment-resistant hypertension, demonstrating efficacy and safety as an adjunct therapy.
A head-to-head comparison of ketogenic and Mediterranean diets demonstrates comparable benefits on weight, blood pressure, and metabolic health in overweight hypertensive adults over three months.
This study quantifies how established, social-psychological, and reproductive factors contribute to stroke risk in women, highlighting the need for integrated prevention strategies across age groups.
This article explains why stopping hypertension medication without medical guidance is not recommended, emphasizing the importance of ongoing treatment, lifestyle changes, and regular monitoring.
Emerging evidence links gut microbiome alterations to hypertension, offering novel therapeutic opportunities. Interventions like dietary fiber, probiotics, and even fecal microbiota transplantation show promise for patients with treatment-r